PRODAS

Elan Pharma International Limited

Application Filed: 1997-04-29
Trademark Application Details
Trademark Logo PRODAS
800
Live/Registered
REGISTERED AND RENEWED
Research OneLook Acronym Finder
Serial Number75283262
Registration Number2361023
Mark Drawing Code1000: Typeset: Word(s)/letter(s)/number(s)
Attorney NameMichele M. Simkin and Norm J. Rich
Attorney Docket Number029318-1268
Law Office AssignedL50
Employee NamePOWERS, ALEXANDER L

Timeline

1997-04-29Application Filed
2000-04-04Published for Opposition
2000-06-27Trademark Registered
2010-05-04Location: GENERIC WEB UPDATE
2010-05-04Status: Live/Registered
2010-06-27Renewal Date
2019-06-27Transaction Date

Trademark Applicants & Owners

Owner: ELAN PHARMA INTERNATIONAL LIMITED
Entity StatementPRIVATE LIMITED COMPANY
AddressMONKSLAND, ATHLONE CO. WESTMEATH IE
Legal Entity Type
Legal Entity State IE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Michele M. Simkin and Norm J. Rich
Foley & Lardner LLP
3000 K Street, N.W., Sixth Floor
WASHINGTON DC 20007-5143

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051tablet matrix used to improve the solubility and absorption characteristics of poorly water soluble drugs sold as an integral component of various oral pharmaceuticals, namely, antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, cns stimulants, analgesics, antipyretics and anti-infammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, desensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents, for administration to humans

Trademark Filing History

DescriptionDateEvent Coding
ASSIGNED TO EXAMINER1997-11-241 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER1997-11-262 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED1997-11-283 CNRT F:First Action
CORRESPONDENCE RECEIVED IN LAW OFFICE1998-05-284 CRFA I:Incoming Correspondence
LETTER OF SUSPENSION MAILED1998-06-295 CNSL F:First Action
INQUIRY AS TO SUSPENSION MAILED1998-12-146 CNSI O:Outgoing Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE1999-06-117 CRFA I:Incoming Correspondence
LETTER OF SUSPENSION MAILED1999-07-148 CNSL F:First Action
CORRESPONDENCE RECEIVED IN LAW OFFICE1999-10-079 CRFA I:Incoming Correspondence
INQUIRY AS TO SUSPENSION MAILED1999-11-0810 CNSI O:Outgoing Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE1999-11-0411 CRFA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER1999-12-3012 CNSA O:Outgoing Correspondence
NOTICE OF PUBLICATION2000-03-0313 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION2000-04-0414 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER2000-06-2715 R.PR A:Allowance for Publication
CASE FILE IN TICRS2006-03-2416 CFIT O:Outgoing Correspondence
PAPER RECEIVED2006-06-2617 MAIL I:Incoming Correspondence
REVIEW OF CORRESPONDENCE COMPLETE2006-10-1818 CORV P:
CANCELLED SEC. 8 (6-YR)2007-03-3119 C8.. O:Outgoing Correspondence
FAX RECEIVED2009-10-1620 FAXX I:Incoming Correspondence
FAX RECEIVED2009-10-2321 FAXX I:Incoming Correspondence
FAX RECEIVED2009-10-2322 FAXX I:Incoming Correspondence
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED2006-06-2623 815F I:Incoming Correspondence
REINSTATED2009-11-1224 REIN I:Incoming Correspondence
FAX RECEIVED2009-11-1625 FAXX I:Incoming Correspondence
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2009-11-2026 C15A O:Outgoing Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2010-02-0327 ASGN I:Incoming Correspondence
TEAS SECTION 8 & 9 RECEIVED2010-05-0328 E89R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2010-05-0429 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED2010-05-0430 89AG O:Outgoing Correspondence
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)2010-05-0431 RNL1 Q:
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2011-10-0532 ASCK I:Incoming Correspondence
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2012-10-1733 ASCK I:Incoming Correspondence
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2013-10-1634 ASCK I:Incoming Correspondence
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED2019-06-2735 REM2 E:E-Mail
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 92021-10-2936 CAEX O:Outgoing Correspondence
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2022-01-2637 ASCK I:Incoming Correspondence
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2022-06-2338 ASCK I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed